LLS Discovery Grant Program
The Leukemia & Lymphoma Society’s Discovery Grant Program funds pioneering basic research into blood-cancer biology, innovative biomarker discovery, and proof-of-concept studies to uncover novel therapeutic targets and mechanisms.
Eligibility Criteria:
-
PI must be an established investigator (>3 years independent faculty appointment).
-
Research must focus on blood-cancer mechanisms (clonal evolution, autophagy, metabolism, resistance, microenvironment, neoantigens).
-
Excludes clinical trials, drug development beyond proof-of-concept, confirmatory/minimally incremental work, normal hematopoiesis studies, and current DGP/BCDG awardees.
Funding Details:
-
Award Ceiling: Up to $250,000 USD/year ($750,000 USD total over 3 years), inclusive of indirect costs (max 10%).
-
Funds may cover personnel, supplies, equipment, and overhead.
Deadline:
-
LOI Due: August 19, 2025, 3:00 PM ET
-
Full Application Deadline (invitees): November 19, 2025, 3:00 PM ET
-
Awards announced April 2026; funding starts July 1, 2026.
Where to Go for Further Information:
Download 2025 DGP Guidelines & Instructions and the Funding Agreement Template from the LLS Research Portal:
Register or request an account there, and follow the portal’s submission instructions.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023